Abrdn Healthcare Opportunities Fund (NYSE:THQ) Trading Down 0.6% – Time to Sell?

Abrdn Healthcare Opportunities Fund (NYSE:THQ)’s share price traded down 0.6% on Monday . The company traded as low as $18.25 and last traded at $18.31. 82,329 shares were traded during trading, a decline of 47% from the average session volume of 156,762 shares. The stock had previously closed at $18.42.

Abrdn Healthcare Opportunities Fund Stock Performance

The stock’s fifty day moving average is $17.88 and its two-hundred day moving average is $18.55.

Abrdn Healthcare Opportunities Fund Announces Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, May 29th. Stockholders of record on Thursday, May 21st will be paid a $0.18 dividend. The ex-dividend date of this dividend is Thursday, May 21st. This represents a c) dividend on an annualized basis and a dividend yield of 11.7%.

Institutional Investors Weigh In On Abrdn Healthcare Opportunities Fund

A number of institutional investors have recently made changes to their positions in THQ. Heron Bay Capital Management boosted its stake in shares of Abrdn Healthcare Opportunities Fund by 20.6% in the 4th quarter. Heron Bay Capital Management now owns 592,723 shares of the company’s stock valued at $11,339,000 after purchasing an additional 101,439 shares in the last quarter. Landscape Capital Management L.L.C. purchased a new stake in shares of Abrdn Healthcare Opportunities Fund in the 3rd quarter valued at $1,479,000. Evolve Private Wealth LLC purchased a new stake in shares of Abrdn Healthcare Opportunities Fund in the 4th quarter valued at $1,436,000. Wolverine Asset Management LLC purchased a new stake in shares of Abrdn Healthcare Opportunities Fund in the 3rd quarter valued at $1,197,000. Finally, Susquehanna International Group LLP purchased a new stake in Abrdn Healthcare Opportunities Fund during the 3rd quarter valued at $1,157,000.

Abrdn Healthcare Opportunities Fund Company Profile

Abrdn Healthcare Opportunities Fund (NYSE: THQ) is a closed-end management investment company that seeks to deliver total return through a combination of current income and capital appreciation. The fund invests primarily in equity and debt securities issued by companies across the healthcare industry, including pharmaceuticals, biotechnology, medical devices, healthcare services and health insurance. It trades on the New York Stock Exchange under the symbol THQ.

With a sector-focused approach, the fund’s portfolio is weighted toward companies demonstrating strong growth potential, resilient cash flows and innovative product pipelines.